Operations research models of hepatitis B prove decisive in treating millions in US, China
Tuesday, July 26, 2011 - 20:30
in Health & Medicine
With hepatitis B infecting as many as 10 percent of people of Asian descent, operations researchers collaborated with a liver transplant surgeon to develop mathematical models that verified the cost effectiveness of hepatitis B interventions. These interventions now successfully screen, treat, and vaccinate millions of Asian and Pacific Islander adults in the US and millions of children in China, according to a new paper.